Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

‘Thinkers And Innovators’: How Pelin Wood Thorogood Is Pioneering Proof-As-A-Service For Clinical Trials

Por: Forbes Tech November 14, 2022

thumbnail

Pelin Wood Thorogood is a co-founder of Radicle Science, along with Dr. Jeff Chen. Pelin Thorogood is a tech executive turned impact entrepreneur who co-founded in 2018, an AI-driven health tech benefit corporation (B-corp). She also serves as Executive Chair for Radicle Science. Ms. Thorogood was previously Chief Marketing Officer of WebSideStory, which was acquired by Adobe/Omniture in 2008, and CEO of Anametrix, acquired by Ensighten in 2015,... + full article



Similar News

Importance of participation in clinical trials

WPLG Local 10 USA Health November 18, 2022

thumbnailDEERFIELD BEACH, Fla. – Incredible breakthroughs in the treatment of many diseases, including cancer, are the result of people participating in clinical trials.When Ana Santana was diagnosed with breast cancer three years ago, she went through chemo, radiation and surgery,... + más

Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes

Council Post: How Voice Response Technology Can Aid Clinical Trials | Forbes


Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A

The Advocate USA Health November 16, 2022

thumbnailWhy do people resist enrolling in clinical trials for Alzheimer’s disease?Some of the key challenges that researchers face in conducting studies on Alzheimer’s disease and recruiting candidates include barriers such as lack of time, lack of available diagnostic clinical... + más

Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A | The Advocate

Alzheimer's Treatment Shows Promise in Early Results of Study, Drugmaker Says | NBC 6 South Florida


Council Post: 'Stayin' Alive': Patient Centricity In Decentralized Clinical Trials

Forbes USA Tech November 11, 2022

thumbnailYerramalli Subramaniam is CTO of , a technology leader in DCT and unified platform. getty Whether you're a brother or whether you're a mother, you're stayin' alive, stayin' alive. Feel the city breakin' and everybody shakin' and we're... + más

Council Post: How Voice Response Technology Can Aid Clinical Trials | Forbes

Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes


Council Post: How Voice Response Technology Can Aid Clinical Trials

Forbes USA Tech November 11, 2022

thumbnail, Chief Experience Officer, THREAD Research. getty The Elephant In The Drug Development Room Clinical trials are the FDA-mandated process by which pharmaceutical companies confirm that the efficacy and safety of their new drugs make them worthy of government approval, then... + más

Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes

Council Post: 'Stayin' Alive': Patient Centricity In Decentralized Clinical Trials | Forbes


Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities

Forbes USA Business October 03, 2022

thumbnailGreenphire is working to make clinical trials more equitable and accessible to everyone. Google Images Clinical trial company Greenphire as “the leading provider of global financial lifecycle management solutions for clinical trials, delivering the most complete data and... + más

Market turbulence, inflation, geopolitical uncertainty prompt dip in fintech investment: KPMG | Fox Business

Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A | The Advocate


Shocked By Disparities In Access To Clinical Trials, This Medical Student Decided To Change Things

Forbes USA Business October 01, 2022

thumbnailFrustrated by inequities in the healthcare system, Manuri Gunawardena left medical school to try to tackle the problem head on. She founded , which helps people find appropriate clinical trials for a wide range of conditions, using a unique algorithm , in 2019. “There are very... + más

Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A | The Advocate

Facebook ad ban may squelch medical research recruitment | Politico


Risk concerns, comorbidities and more keep many from clinical trials: Alzheimers Q&A

The Advocate USA Health September 26, 2022

thumbnailWhy do people resist enrolling in clinical trials for Alzheimer’s disease?Some of the key challenges that researchers face in conducting studies on Alzheimer’s disease and recruiting candidates include barriers such as lack of time, lack of available diagnostic clinical... + más

Alzheimer's Treatment Shows Promise in Early Results of Study, Drugmaker Says | NBC 6 South Florida

Facebook ad ban may squelch medical research recruitment | Politico



About iurex | Privacy Policy | Disclaimer |